文献速递白内障与屈光手术

维生素D补充与澳大利亚老年人白内障手术发生率

Vitamin D Supplementation and the Incidence of Cataract Surgery in Older Australian Adults.
PubMed 文献 · Ophthalmology · 2022-09-27

本研究为D-健康试验的辅助研究,随机双盲安慰剂对照,纳入19 925名60至84岁澳大利亚居民,每月口服60 000 IU维生素D3或安慰剂,中位随访5年;维生素D组与安慰剂组白内障手术发生率相似(每1000人年41.6 vs 41.1,HR 1.02,95%CI 0.95-1.09)。

要点

  • 在维生素D缺乏低流行的地区,常规高剂量补充维生素D不太可能减少老年人白内障手术需求。
  • 维生素D组与安慰剂组白内障手术发生率相似,风险比(HR)为1.02(95%CI 0.95-1.09)。
  • 预设亚组分析中,年龄、性别、体重指数、预测血清25(OH)D浓度或环境紫外线辐射均未改变维生素D补充对白内障手术发生率的影响。

核心结论

  • 在维生素D缺乏低流行的地区,对老年人常规补充高剂量维生素D不太可能减少白内障手术需求。

研究设计与样本

  • D-健康试验的辅助研究,随机双盲安慰剂对照试验,2014年至2020年在澳大利亚一般人群中进行。
  • 共邀请421 207名60至84岁男性和女性参与,另有1896名志愿者,40 824人表示兴趣;排除高钙血症、甲状旁腺功能亢进、肾结石、骨软化症或结节病者,或每日补充维生素D超过500 IU者;最终21 315人被随机分组。
  • 排除1390名不符合本分析资格者(链接数据可用,但前6个月内无白内障)后,纳入19 925人;中位随访5年。

主要发现

  • 在19 925名符合分析条件的参与者中(平均年龄69.3岁,46%为女性),随访期间3668人(18.4%)接受了白内障手术(维生素D组1841人[18.5%],安慰剂组1827人[18.3%])。
  • 维生素D组与安慰剂组白内障手术发生率相似(每1000人年41.6 vs 41.1;风险比1.02;95%CI 0.95-1.09)。
  • 预设亚组分析中,维生素D补充对白内障手术发生率的影响未受年龄、性别、体重指数、预测血清25(OH)D浓度或环境紫外线辐射的修饰。

关键数值与推荐

  • 参与者每月口服60 000 IU维生素D3(n=10 662)或安慰剂(n=10 653),最长5年。
  • 主要结局为首次白内障手术治疗,通过链接至全民健康保险记录和医院数据确认。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Observational studies suggest that higher serum 25-hydroxy vitamin D (25(OH)D) concentration may be associated with lower risk of cataract. However, no randomized controlled trials have assessed the effect of vitamin D supplementation on the incidence of cataract. We aimed to assess whether vitamin D supplementation reduces the incidence of cataract surgery. DESIGN: We conducted an ancillary study of the D-Health Trial, a randomized, double-masked, placebo-controlled trial of monthly vitamin D conducted from 2014 through 2020 within the Australian general population. PARTICIPANTS: We invited 421 207 men and women 60 to 84 years of age to participate; including an additional 1896 volunteers, 40 824 expressed interest. Those with hypercalcemia, hyperparathyroidism, kidney stones, osteomalacia, or sarcoidosis or those who were taking more than 500 international units (IU) supplemental vitamin D per day were excluded. A total of 21 315 were randomized, and 1390 participants did not fulfil the eligibility criteria for this analysis (linked data available, no cataract within first 6 months), leaving 19 925 included. The median follow-up was 5 years. METHODS: Participants took 60 000 IU of vitamin D3 (n = 10 662) or placebo (n = 10 653) orally once per month for a maximum of 5 years. MAIN OUTCOME MEASURES: The primary outcome for this analysis was the first surgical treatment for cataract, ascertained through linkage to universal health insurance records and hospital data. RESULTS: Among 19 925 participants eligible for this analysis (mean age, 69.3 years; 46% women) 3668 participants (18.4%) underwent cataract surgery during follow-up (vitamin D: n = 1841 [18.5%]; placebo: n = 1827 [18.3%] ). The incidence of cataract surgery was similar between the two groups (incidence rate, 41.6 and 41.1 per 1000 person-years in the vitamin D and placebo groups, respectively; hazard ratio, 1.02; 95% confidence interval, 0.95-1.09). In prespecified subgroup analyses, the effect of vitamin D supplementation on the incidence of cataract surgery was not modified by age, sex, body mass index, predicted serum 25(OH)D concentration, or ambient ultraviolet radiation. CONCLUSIONS: Routinely supplementing older adults who live in an area with a low prevalence of vitamin D deficiency with high-dose vitamin D is unlikely to reduce the need for cataract surgery. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Rahman ST, Waterhouse M, Romero BD, et al. Vitamin D Supplementation and the Incidence of Cataract Surgery in Older Australian Adults. Ophthalmology. 2022. PMID: 36174848. doi:10.1016/j.ophtha.2022.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。